Think Outside the Box With Intravenous Iron—The New Ferric Carboxymaltose FDA Boxed Warning
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This Viewpoint discusses the new US Food and Drug Administration (FDA) boxed warning for intravenous ferric carboxymaltose, how the warning does not go far enough in explaining the potential dangers, and the risks vs benefits of the drug’s use.
Appeared: Wednesday, November 11. JAMA. Peer-reviewed journal.